Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


Delayed Quote. Delayed Nyse - 09/22 04:10:00 pm
51.01 USD   -0.06%
08:12aCARDINAL HEALTH : 2021 Proxy Statement
09/22CARDINAL HEALTH : reinvents hospital claims remittance with comprehensive approach
09/14Cardinal Health to Seek M&A
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cardinal Health : Trial against opioid distributors wraps up in West Virginia

07/28/2021 | 06:05pm EDT

CHARLESTON, W.Va. (AP) — Attorneys for major drug distributors made their final pleas to a federal judge Wednesday to absolve them while placing the blame elsewhere for a prescription pill health emergency in a part of West Virginia.

Defense attorneys tried to find holes in assertions by the plaintiffs and their witnesses as two-day closing arguments wrapped up in the bench trial of a lawsuit against distributors AmerisourceBergen Drug Co., Cardinal Health Inc. and McKesson Corp.

In a state that has had the nation’s highest fatal opioid overdose rate, Cabell County and the city of Huntington are seeking more than $2.5 billion from the distributors that would go toward abatement efforts. A verdict isn't expected for at least three weeks.

Some 81 million pills were sent to the community of about 100,000 along the Ohio River from 2006 to 2014. The lawsuit accused the companies of creating a “public nuisance” with the onslaught and ignoring the signs that the area was being ravaged by addiction.

The companies have placed the responsibility on doctors writing prescriptions and say poor communication and pill quotas set by federal agents also were to blame.

Cardinal Health attorney Enu Mainigi tried to minimize the company’s involvement during her nearly two-hour closing argument, saying that over 32 days at trial, the court heard little about its conduct.

“None of the evidence shows Cardinal Health’s conduct was unreasonable,” Mainigi said. “There’s no witness that has given the court a basis to find that we were a direct cause.”

She also said distributors are not responsible for the diversion of pills from patients into others' hands, whether that medication is sold, stolen or given away.

“That's a crime," she said. “And Cardinal Health can’t stop any of that from happening.”

According to testimony, there were nearly 6,500 overdoses in Huntington and Cabell County from 2015 to 2020, while there were 1,151 drug-related deaths from 2001 to 2018. About 2,500 babies have been born exposed to drugs and 8,252 people suffer from opioid use disorder — or about 10% of the current population.

Like Mainigi, McKesson attorney Timothy Hester tried to downplay his company's role, saying that 76% of McKesson's pill shipments went to a veterans hospital in Huntington.

“McKesson did not distribute 81 million pills,” Hester said.

He said higher pill volumes in the county were driven by an increase in prescriptions, and he echoed Mainigi in saying the plaintiffs’ claim of harm was caused by pill diversion. However, no evidence was given by the plaintiffs that pills were diverted from VA shipments, Hester said.

“The key players who contributed to this volume of prescription opioids are not parties here," including doctors, drug dealers, pill manufacturers, pharmacies and three pill distributors in the area who are bigger than McKesson but are not part of the case, Hester said.

Plaintiff attorney Paul Farrell, representing Cabell County, said he took “great offense” at some of the defense's comments, including a notion that the distributors had no responsibility to control the supply of pills. If that were the case, the pills shouldn't need a registration as required with the federal government.

"They should just be in delivery trucks," Farrell said.

Farrell said the distributors had a duty to block larger orders that were deemed suspicious. “If the number of pills that came into Huntington and Cabell County, West Virginia, isn't suspicious, I don't know what is,” he said.

“We had 81 million pills,” Farrell said. “And it wasn’t by accident.”

Similar lawsuits have resulted in multimillion-dollar settlements, but this is the first time allegations have wound up at federal trial. The result could have huge effects on similar lawsuits that have been filed across the country.

Last week, lawyers for state and local governments announced a potential $26 billion settlement over the toll of opioids with AmerisourceBergen, Cardinal Health and McKesson as well as drugmaker Johnson & Johnson. After full details are shared, each state will have 30 days to decide whether to join. And local governments will have five months after that to decide. If governments don’t opt in, the settlement total would go down.

In separate, similar lawsuits, the state of West Virginia reached a $37 million settlement with McKesson in 2019, and $20 million with Cardinal Health and $16 million with AmerisourceBergen in 2017.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about CARDINAL HEALTH, INC.
08:12aCARDINAL HEALTH : 2021 Proxy Statement
09/22CARDINAL HEALTH : reinvents hospital claims remittance with comprehensive approach
09/14Cardinal Health to Seek M&A
09/14CARDINAL HEALTH : 2021 Annual Report (PDF 2.17 MB)
09/06GLOBAL MARKETS LIVE : Puma, Boeing, Holcim, Revolut, Amazon...
09/06ABC, CAH, MCK - Distributors Announce Proposed Opioid Settlement Will Proceed to Next P..
09/04Drug companies say enough U.S. states join $26 billion opioid settlement to proceed
09/04MCKESSON, AMERISOURCEBERGEN, CARDINA : Letters reviewed by reuters
08/31CARDINAL HEALTH : Supporting Pelotonia's goal to fund equitable cancer research
08/27CARDINAL HEALTH : trade; Nuclear & Precision Health Solutions and IRE ELiT support the gro..
More news
Analyst Recommendations on CARDINAL HEALTH, INC.
More recommendations
Financials (USD)
Sales 2022 173 B - -
Net income 2022 1 317 M - -
Net Debt 2022 1 272 M - -
P/E ratio 2022 11,3x
Yield 2022 3,92%
Capitalization 14 815 M 14 815 M -
EV / Sales 2022 0,09x
EV / Sales 2023 0,08x
Nbr of Employees 46 827
Free-Float 88,8%
Duration : Period :
Cardinal Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARDINAL HEALTH, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 15
Last Close Price 51,01 $
Average target price 57,23 $
Spread / Average Target 12,2%
EPS Revisions
Managers and Directors
Michael C. Kaufmann Chief Executive Officer & Director
Jason M. Hollar Chief Financial Officer
Gregory B. Kenny Independent Non-Executive Chairman
Brian S. Rice Chief Information Officer & Executive VP
Jessica L. Mayer Chief Compliance & Legal Officer
Sector and Competitors